SCHEMBL17574591

SCHEMBL17574591

COc1cc(C=O)cnc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.46
ALDH1A1 P00352 12/20 0.44
TSHR P16473 1/20 0.44
HPGD P15428 3/20 0.41
TRIM24 O15164 1/20 0.41
ALDH5A1 P51649 1/20 0.41
ABAT P80404 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
MAPT P10636 6/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 1/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20304821 0.85 FDPS (0.47) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL23905099 0.82 KIF11 (0.42) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL17574504 0.81 ALDH1A1 (0.43) FDPSALDH1A1TSHRPOLBSMN1; SMN2
SCHEMBL336270 0.79 ALDH1A1 (0.37) ALDH1A1POLB
SCHEMBL29954529 0.77 FDPS (0.50) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL30345174 0.75 KIF11 (0.39) ALDH1A1POLBSMN1; SMN2
SCHEMBL29936033 0.75 FDPS (0.51) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL29950972 0.75 FDPS (0.51) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL25355441 0.75 FDPS (0.51) FDPSALDH1A1TSHRHPGDTRIM24
SCHEMBL13921771 0.75 ACHE (0.39) ALDH1A1TSHRHPGDGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884860-B2 Fused pyrroledicarboxamides and their use as pharmaceuticals SANOFI (FR) 2018-02-06 US disclosed
EP-2809669-B1 FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-02-01 EP disclosed
US-20160159793-A1 Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals SANOFI (FR) 2016-06-09 US disclosed
US-9284333-B2 Fused pyrroledicarboxamides and their use as pharmaceuticals SANOFI (FR) 2016-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159793-A1 Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals KCNA1, KCNE1, KCNH1 FDPS 883/4885ALDH1A1 716/4885TSHR 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.